Covered recipient · General Payments record
ANNA BELITS
General Payments · PY2024
$474.87
- Reported across 10 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $474.87 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| SK Life Science, Inc. | $130.45 | 1 |
| Alexion Pharmaceuticals, Inc. | $122.44 | 1 |
| Neurelis, Inc. | $105.18 | 3 |
| UCB, Inc. | $40.90 | 2 |
| Vanda Pharmaceuticals Inc. | $29.97 | 1 |
| Merz Pharmaceuticals, LLC | $28.79 | 1 |
| Lundbeck LLC | $17.14 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $474.87 | 10 |
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
Program year 2024
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $122.44 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110513954 | CMS |
| Lundbeck LLC | $17.14 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145896283 | CMS |
| Merz Pharmaceuticals, LLC | $28.79 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137946737 | CMS |
| Neurelis, Inc. | $25.53 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145633765 | CMS |
| Neurelis, Inc. | $42.20 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145633770 | CMS |
| Neurelis, Inc. | $37.45 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145633774 | CMS |
| SK Life Science, Inc. | $130.45 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154136348 | CMS |
| UCB, Inc. | $20.14 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143128030 | CMS |
| UCB, Inc. | $20.76 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143128034 | CMS |
| Vanda Pharmaceuticals Inc. | $29.97 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133896541 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.